Pulmonx (LUNG) Short-term Investments (2019 - 2025)

Pulmonx (LUNG) has 6 years of Short-term Investments data on file, last reported at $8.8 million in Q2 2025.

• Short-term Investments for Q2 2025 came in at $8.8 million, down 82.85% year-over-year; the trailing twelve-month figure through Jun 2025 was $8.8 million (down 82.85% YoY), and the FY2024 annual result was $30.6 million, down 8.87% from the prior year.
• Short-term Investments fell to $8.8 million in Q2 2025 per LUNG's latest filing, from $14.1 million in the prior quarter.
• Over five years, Short-term Investments peaked at $51.1 million in Q2 2024 and troughed at $8.8 million in Q2 2025.
• A 5-year average of $30.8 million and a median of $33.6 million in 2023 frame the typical range for Short-term Investments.
• The sharpest annual moves came in 2022 and 2025: Short-term Investments surged 318.17% in 2022, then sank 82.85% in 2025.
• A 5-year view of Short-term Investments shows it stood at $31.6 million in 2021, then advanced by 24.84% to $39.4 million in 2022, then declined by 14.84% to $33.6 million in 2023, then slipped by 8.87% to $30.6 million in 2024, then slumped by 71.35% to $8.8 million in 2025.
• Business Quant data shows LUNG's Short-term Investments at $8.8 million in Q2 2025, $14.1 million in Q1 2025, and $30.6 million in Q4 2024.